In response to DNA adducts, ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3-related) kinases undergo activation, phosphorylate CHK1/CHK2 and p53, thereby triggering death and growth inhibition of cancer cells [4]. The gene discussed is TP53; the disease is cancer.